Efficacy of naloxone in reducing hypoxemia and duration of immobility following focal to bilateral tonic–clonic seizures

Release of endogenous opioids might participate in the severity of post-ictal hypoxemia and immobility after focal to bilateral tonic-clonic seizures (FBTCS). We conducted a multicenter double-blind randomized placebo-controlled trial evaluating the efficacy of an opioid antagonist, naloxone (NLX), administered within 2 min following the end of FBTCS. The efficacy of NLX was further explored with a comparison with historical control. NLX did not improve the delay of recovery or the severity of post-ictal hypoxemia. Post-ictal immobility was significantly shorter in the NLX group when compared to historical control. The impact of these results on SUDEP prevention will require additional studies.

Authors

Institutions

Publication Details

Journal
Epilepsia Open
Published
2025-04-28
DOI
https://doi.org/10.1002/epi4.70046
Citations
3
Primary Topic
Neuroscience of respiration and sleep
Type
article
Field-Weighted Citation Impact
2.74

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy of naloxone in reducing hypoxemia and duration of immobility following focal to bilateral tonic–clonic seizures

Sylvain Rheims, Philippe Ryvlin, Jérôme Petit, Anca Nica et al.
3 citations
Epilepsia Open
Neuroscience of respiration and sleep
2.74
article

Efficacy of naloxone in reducing hypoxemia and duration of immobility following focal to bilateral tonic–clonic seizures

Sylvain Rheims, Philippe Ryvlin, Jérôme Petit, Anca Nica, Arielle Crespel, Laure Mazzola, Pascal Roy, Julien Biberon, Véronique Michel, Martine Lemesle Martin, Philippe Derambure, Luc Valton, Mathilde Leclercq, Laurent Bezin, Vincent Navarro, Sébastien Boulogne, Édouard Hirsch, Fabrice Bartoloméi, Fatima Chorfa, Louis Maillard, Catherine Mercier, Vincent Rossero
article en
3 citations

Abstract

Release of endogenous opioids might participate in the severity of post-ictal hypoxemia and immobility after focal to bilateral tonic-clonic seizures (FBTCS). We conducted a multicenter double-blind randomized placebo-controlled trial evaluating the efficacy of an opioid antagonist, naloxone (NLX), administered within 2 min following the end of FBTCS. The efficacy of NLX was further explored with a comparison with historical control. NLX did not improve the delay of recovery or the severity of post-ictal hypoxemia. Post-ictal immobility was significantly shorter in the NLX group when compared to historical control. The impact of these results on SUDEP prevention will require additional studies.

Epilepsia OpenVol. 10(3)
Université Claude Bernard Lyon 1 (FR), Université de Tours (FR), Centre National de la Recherche Scientifique (FR), Inserm (FR), Université Fédérale de Toulouse Midi-Pyrénées (FR), Université de Lille (FR), Centre Hospitalier Universitaire Vaudois (CH), Sorbonne Université (FR), Centre de Recherche en Neurosciences de Lyon (FR), Centre Hospitalier Universitaire de Tours (FR), Centre Hospitalier Régional et Universitaire de Nancy (FR), Hospices Civils de Lyon (FR), Hôpital Pellegrin (FR), Pitié-Salpêtrière Hospital (FR), Centre Médical de La Teppe (FR), Maison des Sciences sociales et des Humanités de Dijon (FR), Centre de recherche cerveau et cognition (FR), Institut du Cerveau (FR), Centre Hospitalier Universitaire de Rennes (FR), Centre Hospitalier Universitaire de Saint-Étienne (FR), Hôpital de la Timone (FR), Université de Strasbourg (FR)
Agence Nationale de la Recherche
Good health and well-being
Openalex Percentile: Top 11%
Neuroscience of respiration and sleep
2.74
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.